Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (73.79 KB, 1 trang )
Urticaria
Peroni A, Colato C, Schena D, et al. Urticarial lesions: if not urticaria, what else?
The differential diagnosis of urticaria: part I. Cutaneous diseases. J Am Acad
Dermatol 2010;62:541–555.
Morbilliform
Amstutz U, Ross CJ, Castro-Pastrana LI, et al. HLA-A 31:01 and HLA-B 15:02
as genetic markers for carbamazepine hypersensitivity in children. Clin
Pharmacol Ther 2013;94:142–149.
Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin
treatment in children with infectious mononucleosis. Pediatrics
2013;131:e1424–e1427.
Ferrero NA, Pearson KC, Zedek DC, et al. Case report of drug rash with
eosinophilia and systemic symptoms demonstrating human herpesvirus-6
reactivation. Pediatr Dermatol 2013;30:608–613.
Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia
and systemic symptoms (DRESS): an original multisystem adverse drug
reaction. Results from the prospective RegiSCAR study. Br J Dermatol
2013;169:1071–1080.
Acute Generalized Exanthematous Pustulosis
Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized
exanthematous pustulosis (AGEP)-results of a multinational case-control study
(EuroSCAR). Br J Dermatol 2007;157:989–996.
Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
Canavan TN, Mathes EF, Frieden I, et al. Mycoplasma pneumoniae-induced rash
and mucositis as a syndrome distinct from Stevens-Johnson syndrome and
erythema multiforme: a systemic review. J Am Acad Dermatol 2015;72:239–
245.
Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLAB*1502 screening in Taiwan. N Engl J Med 2011;364:1126–1133.
Ciralsky JB, Sippel KC, Gregory DG. Current ophthalmologic treatment
strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal
necrolysis. Curr Opin Ophthalmol 2013;24:321–328.